These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 10708288

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 6. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 10. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Nov 03; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]

  • 11. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.
    Br J Ophthalmol; 1999 Oct 03; 83(10):1186-9. PubMed ID: 10502584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 03; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 Apr 03; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun 03; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 03; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 19. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
    Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    AIDS; 1999 Jul 09; 13(10):1203-6. PubMed ID: 10416523
    [Abstract] [Full Text] [Related]

  • 20. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL, Perez-Elías MJ, Martí-Belda P, Antela A, Suarez M, Ciancas E, Frutos B, Perez MD, Guerrero A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):130-4. PubMed ID: 9768621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.